REQUEST A DEMO
Total
USD $0.00
Search more companies

Eutilex Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Eutilex Co.,Ltd. Profile Updated: August 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Eutilex Co.,Ltd. is an enterprise based in South Korea. Its main office is in Seoul. It operates in the Pharmaceutical Preparation Manufacturing sector. Eutilex Co.,Ltd. was incorporated on February 27, 2015. There are currently 119 (2025) people employed by Eutilex Co.,Ltd.. The latest financial highlights indicate a net sales revenue increase of 8.06% in 2025. There was a total negative growth of 38.06% in Eutilex Co.,Ltd.’s total assets over the same period. The net profit margin of Eutilex Co.,Ltd. increased by 59.12% in 2025.

Headquarters
1401, 25, Gasan Digital 1-Ro, Geumcheon-Gu
Seoul; Seoul;

Contact Details: Purchase the Eutilex Co.,Ltd. report to view the information.

Website: http://www.eutilex.com

Basic Information
Total Employees:
Purchase the Eutilex Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Eutilex Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Eutilex Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Eutilex Co.,Ltd. report to view the information.
Incorporation Date:
February 27, 2015
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
19.1%
Purchase this report to view the information.
16.8%
Purchase this report to view the information.
8.8%
Subsidiaries
Eutilogics Inc
Company Performance
Financial values in the chart are available after Eutilex Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
8.06%
Total Operating Revenue
20.98%
Operating Profit
15%
EBITDA
36.54%
Net Profit/Loss for the Period
12.57%
Total Assets
-38.06%
Total Equity
-62.82%
Operating Profit Margin
67.27%
Net Profit Margin
59.12%
Return on Equity (ROE)
-93.9%
Debt / Equity
59.95%
Quick Ratio
-0.85%
Cash Ratio
-0.73%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?